Literature DB >> 8099239

Effect of drugs acting on the central nervous system on the lethality in mice of Clostridium perfringens epsilon toxin.

M Nagahama1, J Sakurai.   

Abstract

Lethal activity of Clostridium perfringens epsilon toxin was significantly reduced by the prior administration of barbiturates. Phenothiazine derivatives such as chlorpromazine and trifluoperazine and butyrophenone derivatives such as haloperidol and spiperone delayed the lethal effects in mice. Reserpine completely protected mice against the toxin when 10 mg/kg of the drug was administered 24 hr before the injection of the toxin, but did not protect when the same dose of the drug was given within 60 min before the injection of the toxin. Diazepam, apomorphine and gamma-butyrolactone also resulted in a significant increase in the time to death after the toxin. On the other hand, atropine, diphenhydramine, chlorpheniramine and verapamil provided no protection against the toxin. The administration of the toxin resulted in a significant decrease of dopamine levels in the brain, but no effect on levels of epinephrine and norepinephrine. The data suggest that drugs which directly or indirectly inhibit release and receptors of dopamine may lessen the lethal effects of epsilon toxin in mice.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099239     DOI: 10.1016/0041-0101(93)90178-l

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  7 in total

1.  Neurotoxicity of Clostridium perfringens epsilon-toxin for the rat hippocampus via the glutamatergic system.

Authors:  O Miyamoto; J Minami; T Toyoshima; T Nakamura; T Masada; S Nagao; T Negi; T Itano; A Okabe
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

2.  Clostridium perfringens epsilon toxin targets granule cells in the mouse cerebellum and stimulates glutamate release.

Authors:  Etienne Lonchamp; Jean-Luc Dupont; Laetitia Wioland; Raphaël Courjaret; Corinne Mbebi-Liegeois; Emmanuel Jover; Frédéric Doussau; Michel R Popoff; Jean-Louis Bossu; Jean de Barry; Bernard Poulain
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

Review 3.  Pathogenesis and diagnostic features of brain and ophthalmic damage produced by Clostridium perfringens type D epsilon toxin.

Authors:  John W Finnie; Mauricio A Navarro; Francisco A Uzal
Journal:  J Vet Diagn Invest       Date:  2020-01-20       Impact factor: 1.279

4.  Evidence for a prepore stage in the action of Clostridium perfringens epsilon toxin.

Authors:  Susan L Robertson; Jihong Li; Francisco A Uzal; Bruce A McClane
Journal:  PLoS One       Date:  2011-07-11       Impact factor: 3.240

Review 5.  Pathology and Pathogenesis of Brain Lesions Produced by Clostridium perfringens Type D Epsilon Toxin.

Authors:  John W Finnie; Francisco A Uzal
Journal:  Int J Mol Sci       Date:  2022-08-12       Impact factor: 6.208

6.  Clostridium perfringens epsilon toxin increases the small intestinal permeability in mice and rats.

Authors:  Jorge Goldstein; Winston E Morris; César Fabián Loidl; Carla Tironi-Farinati; Carla Tironi-Farinatti; Bruce A McClane; Francisco A Uzal; Mariano E Fernandez Miyakawa
Journal:  PLoS One       Date:  2009-09-18       Impact factor: 3.240

7.  Clostridium perfringens epsilon toxin H149A mutant as a platform for receptor binding studies.

Authors:  Monika Bokori-Brown; Maria C Kokkinidou; Christos G Savva; Sérgio Fernandes da Costa; Claire E Naylor; Ambrose R Cole; David S Moss; Ajit K Basak; Richard W Titball
Journal:  Protein Sci       Date:  2013-04-08       Impact factor: 6.725

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.